Heparin-induced thrombocytopenia (HIT) in patients on hemodialysis: an update.
Szromba
Charlotte
C
Nephrology Clinical Solutions, Chicago, IL, USA. cszromba@att.com
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D024802:Nurse's Role; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D006435:Renal Dialysis / Q000451:nursing; D012307:Risk Factors; D013917:Thrombin / Q000037:antagonists & inhibitors; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D013917:Thrombin